Our science

Neuroplastogen research
for cancer supportive care

We are developing novel small molecules to address the effects of cancer and its treatment on the nervous system.

Research focus

The role of neural plasticity
in cancer supportive care

Neural plasticity is the nervous system’s ability to adapt. We are studying its potential role in cancer supportive care.

We investigate compounds designed to engage pathways involved in neural plasticity and neuroinflammation. For our lead program, we aim to develop an oral medicine suitable for routine oncology care.

Preclinical studies are needed to establish whether these compounds produce the intended biological effects. Clinical trials would then assess whether they benefit patients.

Drug development

Our research approach

01

Medicinal chemistry

We design and evaluate novel small molecules for a defined therapeutic objective, taking the requirements of drug development into account from the outset.

02

Pharmacology & safety

We study receptor activity, brain exposure, selectivity and safety to assess each program and determine which studies are needed next.

03

Translational research

We plan studies of neural plasticity and functional outcomes in models relevant to cancer and its treatment.

04

Clinical perspective

We consider which outcomes matter to patients and how a treatment could be used in oncology care when planning our development programs.

Our lead program

TL-01

TL-01 is a preclinical neuroplastogen research program based on serotonin receptor pharmacology.

We are initially developing TL-01 for cancer-related cognitive impairment, often called “chemo brain.” Our goal is an oral medicine that could fit routine oncology care. Reduced perceptual effects are also a research objective.

Receptor and brain exposure studies help us plan the next experiments. Direct studies of neural plasticity, further safety evaluation and research in disease models are still needed. TL-01 has not been tested in humans, so its clinical benefit, subjective effects and monitoring requirements remain unknown.

View the pipeline
Cancer-related cognitive impairment

Cancer treatment can affect thinking, memory and concentration. Read the National Cancer Institute’s overview

Research and partnerships

Work with Telesti

Contact our team